» Articles » PMID: 19812690

Successful Small Intestine Colonization of Adult Mice by Vibrio Cholerae Requires Ketamine Anesthesia and Accessory Toxins

Overview
Journal PLoS One
Date 2009 Oct 9
PMID 19812690
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Vibrio cholerae colonizes the small intestine of adult C57BL/6 mice. In this study, the physical and genetic parameters that facilitate this colonization were investigated. Successful colonization was found to depend upon anesthesia with ketamine-xylazine and neutralization of stomach acid with sodium bicarbonate, but not streptomycin treatment. A variety of common mouse strains were colonized by O1, O139, and non-O1/non-O139 strains. All combinations of mutants in the genes for hemolysin, the multifunctional, autoprocessing RTX toxin (MARTX), and hemagglutinin/protease were assessed, and it was found that hemolysin and MARTX are each sufficient for colonization after a low dose infection. Overall, this study suggests that, after intragastric inoculation, V. cholerae encounters barriers to infection including an acidic environment and an immediate immune response that is circumvented by sodium bicarbonate and the anti-inflammatory effects of ketamine-xylazine. After initial adherence in the small intestine, the bacteria are subjected to additional clearance mechanisms that are evaded by the independent toxic action of hemolysin or MARTX. Once colonization is established, it is suggested that, in humans, these now persisting bacteria initiate synthesis of the major virulence factors to cause cholera disease. This adult mouse model of intestinal V. cholerae infection, now well-characterized and fully optimized, should serve as a valuable tool for studies of pathogenesis and testing vaccine efficacy.

Citing Articles

Non-O1/Non-O139 -An Underestimated Foodborne Pathogen? An Overview of Its Virulence Genes and Regulatory Systems Involved in Pathogenesis.

Zhang Q, Alter T, Fleischmann S Microorganisms. 2024; 12(4).

PMID: 38674762 PMC: 11052320. DOI: 10.3390/microorganisms12040818.


Biofilm formation on human immune cells is a multicellular predation strategy of Vibrio cholerae.

Vidakovic L, Mikhaleva S, Jeckel H, Nisnevich V, Strenger K, Neuhaus K Cell. 2023; 186(12):2690-2704.e20.

PMID: 37295405 PMC: 10256282. DOI: 10.1016/j.cell.2023.05.008.


Advances in cholera research: from molecular biology to public health initiatives.

Walton M, Cubillejo I, Nag D, Withey J Front Microbiol. 2023; 14:1178538.

PMID: 37283925 PMC: 10239892. DOI: 10.3389/fmicb.2023.1178538.


Intestinal colonization against : host and microbial resistance mechanisms.

Muhammad A, Amonov M, Murugaiah C, Baig A, Yusoff M AIMS Microbiol. 2023; 9(2):346-374.

PMID: 37091815 PMC: 10113163. DOI: 10.3934/microbiol.2023019.


ToxT Regulon Is Nonessential for Vibrio cholerae Colonization in Adult Mice.

Shi M, Zhao F, Li N, Wang Z, Yang M Appl Environ Microbiol. 2022; 88(8):e0007222.

PMID: 35384706 PMC: 9040629. DOI: 10.1128/aem.00072-22.


References
1.
Mekalanos J . Duplication and amplification of toxin genes in Vibrio cholerae. Cell. 1983; 35(1):253-63. DOI: 10.1016/0092-8674(83)90228-3. View

2.
Fullner K, Mekalanos J . Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of Vibrio cholerae. Infect Immun. 1999; 67(3):1393-404. PMC: 96473. DOI: 10.1128/IAI.67.3.1393-1404.1999. View

3.
Ghosh A, Saha D, Hoque K, Asakuna M, Yamasaki S, Koley H . Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain. Infect Immun. 2006; 74(5):2937-46. PMC: 1459690. DOI: 10.1128/IAI.74.5.2937-2946.2006. View

4.
Hsiao A, Liu Z, Joelsson A, Zhu J . Vibrio cholerae virulence regulator-coordinated evasion of host immunity. Proc Natl Acad Sci U S A. 2006; 103(39):14542-7. PMC: 1599996. DOI: 10.1073/pnas.0604650103. View

5.
Olivier V, Salzman N, Satchell K . Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect Immun. 2007; 75(10):5043-51. PMC: 2044531. DOI: 10.1128/IAI.00508-07. View